Eli Lilly

News

More positive results for Pfizer/Lilly’s non-opioid pain dru...

Pfizer and Eli Lilly have announced more positive results from a phase 3 study of their non-opioid pain drug tanezumab, this time in chronic lower back pain (CBLP).

News

Novartis and Lilly CEOs back Trump plans to cut drug prices

CEOs from Novartis and Eli Lilly have backed US government proposals to cut out “middlemen” in the health system, who have inflated the costs of their medicines.

News

Lilly scores with two Olumiant trials in atopic dermatitis

Eli Lilly has two positive trials of its JAK inhibitor Olumiant in skin disorder atopic dermatitis (AD), which could finally unlock the drug’s potential in the US.

News

Novo accelerates launch plans for oral semaglutide

Novo Nordisk has said it is accelerating launch preparations for its new diabetes pill semaglutide, after investing in a voucher that will allow a fast review of the drug in the US.

News

Illustration of a nerve cell on a colored background with light effects

Mixed results for non-opioid pain drug from Pfizer/Lilly

Pfizer and Eli Lilly have produced more phase 3 data that appear to back their non-opioid painkiller tanezumab.

News

A sad young woman is sitting in her kitchen with a headache

CVS covers migraine drugs from Teva and Lilly, excludes Amge...

US pharmacy benefits manager CVS Health Corp has added new migraine drugs from Teva and Eli Lilly to its list of covered drugs but excluded a rival from Amgen, according to a press report.<

More positive results for Pfizer/Lilly’s non-opioid pain dru...

Novartis and Lilly CEOs back Trump plans to cut drug prices

Lilly scores with two Olumiant trials in atopic dermatitis

Novo accelerates launch plans for oral semaglutide

Mixed results for non-opioid pain drug from Pfizer/Lilly

CVS covers migraine drugs from Teva and Lilly, excludes Amge...

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Eli Lilly

Editor's Picks